Citigroup Forecasts Strong Price Appreciation for Albemarle (NYSE:ALB) Stock

Albemarle (NYSE:ALBGet Free Report) had its target price hoisted by research analysts at Citigroup from $95.00 to $100.00 in a report issued on Friday,MarketScreener reports. The firm presently has a “neutral” rating on the specialty chemicals company’s stock. Citigroup’s price target suggests a potential upside of 3.01% from the company’s current price.

Other equities research analysts have also recently issued reports about the stock. Baird R W cut shares of Albemarle from a “hold” rating to a “strong sell” rating in a research report on Tuesday, July 29th. Mizuho raised their target price on shares of Albemarle from $78.00 to $92.00 and gave the stock a “neutral” rating in a report on Friday, October 3rd. Scotiabank upped their price target on Albemarle from $65.00 to $70.00 and gave the company a “sector perform” rating in a report on Friday, August 1st. Deutsche Bank Aktiengesellschaft raised their price objective on Albemarle from $74.00 to $95.00 in a research note on Friday, October 17th. Finally, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Albemarle in a research report on Wednesday, October 8th. One research analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating, fifteen have issued a Hold rating and five have given a Sell rating to the company’s stock. According to MarketBeat.com, Albemarle currently has a consensus rating of “Hold” and a consensus price target of $95.74.

View Our Latest Stock Analysis on Albemarle

Albemarle Stock Performance

ALB opened at $97.08 on Friday. The business has a 50 day moving average price of $88.11 and a two-hundred day moving average price of $74.21. The company has a debt-to-equity ratio of 0.38, a current ratio of 2.31 and a quick ratio of 1.47. The company has a market capitalization of $11.42 billion, a price-to-earnings ratio of -10.42 and a beta of 1.70. Albemarle has a 1-year low of $49.43 and a 1-year high of $113.91.

Albemarle (NYSE:ALBGet Free Report) last issued its quarterly earnings results on Wednesday, November 5th. The specialty chemicals company reported ($0.19) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.92) by $0.73. The company had revenue of $1.31 billion for the quarter, compared to analysts’ expectations of $1.27 billion. Albemarle had a negative return on equity of 1.87% and a negative net margin of 18.61%.The firm’s revenue for the quarter was down 3.5% on a year-over-year basis. During the same period last year, the firm earned ($1.55) EPS. Research analysts predict that Albemarle will post -0.04 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in ALB. Teacher Retirement System of Texas purchased a new stake in Albemarle in the 1st quarter worth approximately $1,238,000. OneDigital Investment Advisors LLC increased its stake in shares of Albemarle by 6.7% in the first quarter. OneDigital Investment Advisors LLC now owns 3,782 shares of the specialty chemicals company’s stock worth $272,000 after acquiring an additional 239 shares during the last quarter. Concurrent Investment Advisors LLC purchased a new stake in shares of Albemarle during the first quarter worth $271,000. Envestnet Asset Management Inc. boosted its position in Albemarle by 3.6% during the first quarter. Envestnet Asset Management Inc. now owns 184,426 shares of the specialty chemicals company’s stock valued at $13,282,000 after purchasing an additional 6,487 shares during the last quarter. Finally, SteelPeak Wealth LLC grew its stake in Albemarle by 6.2% in the first quarter. SteelPeak Wealth LLC now owns 22,310 shares of the specialty chemicals company’s stock valued at $1,615,000 after purchasing an additional 1,298 shares in the last quarter. 92.87% of the stock is owned by hedge funds and other institutional investors.

About Albemarle

(Get Free Report)

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.

See Also

Analyst Recommendations for Albemarle (NYSE:ALB)

Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.